- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02687633
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
The investigators are running an intervention study for young children with Tuberous Sclerosis Complex (TSC). The study will include free play-based behavioral intervention that may improve social and communication skills in children with TSC. Eligible families will have a child in the age range of 12-36 months, with a diagnosis of TSC. A parent must also be available to attend the weekly intervention sessions at UCLA.
The intervention will focus on teaching caregivers skills to improve the social and communication outcomes of their children. The content of the intervention will be individually tailored to the child's developmental level. The intervention involves pre-assessments, an intervention period of daily 60 minute sessions for 10 days, followed by weekly 60 minute sessions for 10 weeks, and post-assessments. The classroom can have up to 3 parent-child dyad and the curriculum focuses on improving social-communication and play skills.
Study Overview
Detailed Description
Most children with Tuberous Sclerosis Complex (TSC) suffer from neurodevelopmental disabilities, including intellectual disability (ID) and autism spectrum disorder (ASD). There is a tremendous need for early intervention for all infants with TSC, with a focus on improving non-verbal cognition and social communication skills. However, no studies have investigated whether early intervention can improve social communication skills in infants with TSC. As a result, families of infants with TSC struggle to receive adequate interventions targeting these areas of development.
The investigators propose to enroll 32 infants and toddlers with TSC to study an evidence-based behavioral intervention in infants with TSC, combining the efforts of investigators with expertise in autism intervention, infant development, and TSC. The proposed intervention study adapts a parent-mediated treatment called JASPER (Joint attention, symbolic play, engagement, regulation) that has successfully improved social communication outcomes in toddlers and young children with ASD.
JASPER intervention will last 3 months, and is split into two phases. Phase 1 occurs for the first 2 weeks of intervention, and consists of daily 1 hour intervention sessions (Monday through Friday) for 2 weeks. After Phase 1, Phase two begins, and consists of 60 minute sessions once a week for 10 weeks. Participants will receive behavioral assessments and EEG across 4 assessment time points during this study: At the start of participation in the study, two weeks into participation of the study, 3 months into participation of the study, and 6 months into participation in the study. The behavioral assessments administered throughout these time points will measure social communication skills, overall cognitive functioning, and non-verbal communication. EEG is sensitive to subtle changes in the brain and may be able to capture responses to treatment prior to clinical or behavioral change, and can inform researchers of the brain basis for the behavioral changes found with intervention. The EEG at each time point will be 30-45 minutes in length, and will require the participant to be awake, as they will watch several short videos on a tv screen while recording EEG data.
There are 2 randomized participation groups in this study, Treatment Group 1, and Treatment Group 2. Treatment group 1 will begin JASPER intervention immediately, and thus will complete the first 3 assessment time points while in intervention, and the 4th assessment time point 3 months after intervention ends. Treatment Group 2 will complete the 4 assessment time points while receiving services as usual in the community, and will begin intervention after the 4th assessment time point. Treatment group 1 will participate in this study for a total of 6 months, and treatment group 2 will participate in the study for a total of 9 months, since they will receive services in the community as usual for 6 months before beginning the 3 month intervention. Group assignment is randomized, and each participant has an equal chance of being assigned to either treatment group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- UCLA Semel Insitute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A confirmed diagnosis of Tuberous Sclerosis Complex
Exclusion Criteria:
- A mental age less than 6 months. A plan for epilepsy surgery during the study participation period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment Group
The Treatment Group begins the JASPER intervention immediately upon enrollment in the study.
|
JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a treatment approach based on a combination of developmental and behavioral principles developed by Dr. Connie Kasari and Dr. Amanda Gulsrud at UCLA.
It targets the foundations of social communication (joint attention, imitation, play) and uses naturalistic strategies to increase the rate and complexity of social communication.
Other Names:
|
Active Comparator: Delayed Treatment Group
The Delayed treatment group receives the same JASPER intervention as the Treatment Group, but after 6 months of receiving services in the community as usual.
|
JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a treatment approach based on a combination of developmental and behavioral principles developed by Dr. Connie Kasari and Dr. Amanda Gulsrud at UCLA.
It targets the foundations of social communication (joint attention, imitation, play) and uses naturalistic strategies to increase the rate and complexity of social communication.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change from baseline in Joint Engagement (shared engagement in a play routine) at 2 weeks into study participation, according to the parent caregiver interaction assessment.
Time Frame: 2 weeks
|
Parent Caregiver Interaction assesses the amount of time the parent and child spend in engaged in the same play routine.
|
2 weeks
|
change from baseline in Joint Engagement (shared engagement in a play routine) at 3 months into study participation, according to the parent caregiver interaction assessment.
Time Frame: 3 months
|
Parent Caregiver Interaction assesses the amount of time the parent and child spend in engaged in the same play routine.
|
3 months
|
change from baseline in Joint Engagement (shared engagement in a play routine) at 6 months into study participation, according to the parent caregiver interaction assessment.
Time Frame: 6 months
|
Parent Caregiver Interaction assesses the amount of time the parent and child spend in engaged in the same play routine.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in the amount of time spent in a Joint Attention (the coordination of attention between objects and people for the purpose of sharing) state at 2 weeks
Time Frame: 2 weeks
|
ESCS (Early Social Communication Scales) Assessment.
|
2 weeks
|
Change from baseline in the amount of time spent in a Joint Attention (the coordination of attention between objects and people for the purpose of sharing) state at 3 months
Time Frame: 3 months
|
ESCS (Early Social Communication Scales) Assessment.
|
3 months
|
Change from baseline in the amount of time spent in a Joint Attention (the coordination of attention between objects and people for the purpose of sharing) state at 6 months
Time Frame: 6 months
|
ESCS (Early Social Communication Scales) Assessment.
|
6 months
|
Change from baseline in Symbolic Play (types of play and level of play) at 2 weeks, according to the Structured Play Assessment (SPA)
Time Frame: 2 weeks
|
The Structured Play Assessment measures the child's play level, based on distinct sets of toys that target specific developmental markers of play.
|
2 weeks
|
Change from baseline in Symbolic Play (types of play and level of play) at 3 months, according to the Structured Play Assessment (SPA)
Time Frame: 3 months
|
The Structured Play Assessment measures the child's play level, based on distinct sets of toys that target specific developmental markers of play.
|
3 months
|
Change from baseline in Symbolic Play (types of play and level of play) at 6 months, according to the Structured Play Assessment (SPA)
Time Frame: 6 months
|
The Structured Play Assessment measures the child's play level, based on distinct sets of toys that target specific developmental markers of play.
|
6 months
|
Change from baseline at 3 months in developmental quotient, as determined by the Mullen Scales of Early Learning
Time Frame: 3 months
|
Cognition will be determined by a Developmental Quotient on a traditional cognitive measure, the Mullen Scales of Early Learning
|
3 months
|
Change from baseline at 6 months in developmental quotient, as determined by the Mullen Scales of Early Learning
Time Frame: 6 months
|
Cognition will be determined by a Developmental Quotient on a traditional cognitive measure, the Mullen Scales of Early Learning
|
6 months
|
Change from baseline at 2 weeks in the amount of Parent use of social communication support strategies
Time Frame: 2 weeks
|
Parent use of social communication support strategies as taught by JASPER will be measured by a parent-child interaction assessment.
|
2 weeks
|
Change from baseline at 3 months in the amount of Parent use of social communication support strategies
Time Frame: 3 months
|
Parent use of social communication support strategies as taught by JASPER will be measured by a parent-child interaction assessment.
|
3 months
|
Change from baseline at 6 months in the amount of Parent use of social communication support strategies
Time Frame: 6 months
|
Parent use of social communication support strategies as taught by JASPER will be measured by a parent-child interaction assessment.
|
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Shafali Jeste, MD, University of California, Los Angeles
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Neoplasms
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Neurodegenerative Diseases
- Heredodegenerative Disorders, Nervous System
- Neoplastic Syndromes, Hereditary
- Malformations of Cortical Development, Group I
- Malformations of Cortical Development
- Nervous System Malformations
- Neurocutaneous Syndromes
- Hamartoma
- Neoplasms, Multiple Primary
- Sclerosis
- Tuberous Sclerosis
Other Study ID Numbers
- 15-000699
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tuberous Sclerosis Complex
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex Associated Neuropsychiatric DiseaseUnited States, United Kingdom, Poland
-
Novartis PharmaceuticalsCompletedTuberous Sclerosis Complex-associated Refractory SeizuresUnited States, Colombia, Belgium, France, Japan, Taiwan, Turkey, Spain, Thailand, Korea, Republic of, Australia, Hungary, United Kingdom, Canada, Norway, Germany, Italy, Russian Federation, Denmark, Argentina, Netherlands, Greece, P... and more
-
Katarzyna KotulskaRecruitingTuberous Sclerosis ComplexPoland
-
University Hospitals Bristol and Weston NHS Foundation...University College, London; The Tuberous Sclerosis AssociationActive, not recruitingTuberous Sclerosis ComplexUnited Kingdom
-
Children's Hospital Medical Center, CincinnatiMassachusetts General Hospital; The University of Texas Health Science Center... and other collaboratorsCompletedTuberous Sclerosis ComplexUnited States
-
Noema Pharma AGRecruitingTuberous Sclerosis ComplexUnited States, India, Israel, Turkey, Italy, Poland, Spain, United Kingdom
-
NobelpharmaActive, not recruitingTuberous Sclerosis ComplexJapan
-
University Hospital, MontpellierUnknownTuberous Sclerosis ComplexFrance
-
Jazz PharmaceuticalsRecruitingSeizure in Participants With Tuberous Sclerosis Complex | Seizure in Participants With Dravet Syndrome | Seizure in Participants With Lennox-Gastaut SyndromeUnited States
-
Jazz PharmaceuticalsGW PharmaceuticalsCompletedSeizures | Tuberous Sclerosis ComplexUnited States
Clinical Trials on JASPER
-
University of California, Los AngelesNational Institutes of Health (NIH)RecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesSimons FoundationRecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesRecruiting
-
Boston Children's HospitalCompleted
-
University of California, Los AngelesCompletedChildren at Risk for ASDUnited States
-
University of California, Los AngelesNational Institutes of Health (NIH)RecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesUniversity of Massachusetts, WorcesterRecruiting
-
Boston Children's HospitalRecruitingDown SyndromeUnited States
-
Boston University Charles River CampusUniversity of California, Los Angeles; University of Chicago; Boston Medical... and other collaboratorsActive, not recruiting
-
University of California, Los AngelesRecruiting